Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lexicon Pharmaceuticals (Nasdaq: LXRX) will participate in three investor events in March 2026. Management will speak at a Leerink Partners fireside chat on March 11, 2026 at 10:00 a.m. and hold 1x1 meetings at Jefferies Biotech on the Beach and Barclays Global Healthcare, March 10–12.
According to the company, a live recording and replay of the Leerink fireside chat will be available via the company Events page.
Details
News Market Reaction – LXRX
On Mar 4, the first trading day after this news, LXRX closed 1.24% above the previous close.
Data tracked by StockTitan Argus for the Mar 4 session.
Key Figures
- Leerink fireside chat time
- 10:00 a.m.
- Scheduled time on March 11, 2026
- Jefferies summit dates
- March 10–11
- Jefferies Biotech on the Beach Summit participation window
- Barclays conference dates
- March 10–12
- Barclays 28th Global Healthcare Conference participation window
- Barclays conference number
- 28th
- Edition of Barclays Global Healthcare Conference
Historical Context
-
Announced timing of Q4 2025 results and conference call.
-
Closed $94.6M public offering and concurrent private placement.
-
Priced large equity offering and private placement for corporate needs.
-
Proposed underwritten public offering and concurrent private placement.
-
Announced Nasdaq closing-bell event to mark 30th anniversary.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, at 10:00 a.m.
Lexicon will also be participating in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit, March 10–11, and at the Barclays 28th Global Healthcare Conference, March 10-12.
A live recording and replay of the Leerink fireside chat can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.